Discover Tenders by Currency Vending Or Dispenser Machinecashnotechequecoin Sector

Find the most relevant tenders for Currency Vending Or Dispenser Machinecashnotechequecoin. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Currency Vending Or Dispenser Machinecashnotechequecoin tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Currency Vending Or Dispenser Machinecashnotechequecoin tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Not Exclusive Of Am Discount Agreement According To Section 130A Paragraph 8 Sgb V By Means Of An Oh Model For Ws Epoetin Alfa Genetically Engineered Human Erythropoietin Restriction To Packs With Doses Up To 10 000 Iu

Deadline: 31 Jul 2026

Germany

Ref. No.: 5978748

EMD:Ref Document

Bid Value: Ref Document

257 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Filgrastim Atc Code According To Who L03Aa02

Deadline: 30 Jun 2026

Germany

Ref. No.: 5978377

EMD:Ref Document

Bid Value: Ref Document

226 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ebastine In The Strength 20 Mg And The Dosage Form Smt

Deadline: 10 May 2026

Germany

Ref. No.: 5978310

EMD:Ref Document

Bid Value: Ref Document

175 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Somatropin Atc Code According To Who H01Ac01

Deadline: 31 Jul 2026

Germany

Ref. No.: 5977915

EMD:Ref Document

Bid Value: Ref Document

257 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Brimonidine In The Dosage Form Edp

Deadline: 10 May 2026

Germany

Ref. No.: 5977462

EMD:Ref Document

Bid Value: Ref Document

175 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Baclofen In The Dosage Form Inf

Deadline: 10 May 2026

Germany

Ref. No.: 5976401

EMD:Ref Document

Bid Value: Ref Document

175 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of A So Called Open House Model For Medicinal Products With The Trade Name Acarizax R Atc Code According To Who V01Aa03

Deadline: 31 Jul 2026

Germany

Ref. No.: 5975947

EMD:Ref Document

Bid Value: Ref Document

257 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Pegfilgrastim Atc Code According To Who L03Aa13

Deadline: 30 Apr 2026

Germany

Ref. No.: 5975224

EMD:Ref Document

Bid Value: Ref Document

165 Days Left

Deadline: 31 Jul 2026

Germany

Ref. No.: 5975023

EMD:Ref Document

Bid Value: Ref Document

257 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine In The Dosage Form Lse

Deadline: 10 May 2026

Germany

Ref. No.: 5968352

EMD:Ref Document

Bid Value: Ref Document

175 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acarbose Not In Standard Size 2

Deadline: 10 May 2026

Germany

Ref. No.: 5965414

EMD:Ref Document

Bid Value: Ref Document

175 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine As An Otc Medicinal Product

Deadline: 10 May 2026

Germany

Ref. No.: 5965319

EMD:Ref Document

Bid Value: Ref Document

175 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V On Active Ingredients Medicines Vv 77

Deadline: 10 May 2026

Germany

Ref. No.: 5901848

EMD:Ref Document

Bid Value: Ref Document

175 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ranibizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5730369

EMD:Ref Document

Bid Value: Ref Document

175 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Aclidinium Bromide Atc Code According To Who R03Bb05

Deadline: 28 Feb 2026

Germany

Ref. No.: 5727483

EMD:Ref Document

Bid Value: Ref Document

104 Days Left

Showing 2716 to 2730 of 2739 results

Discover Tenders by Currency Vending Or Dispenser Machinecashnotechequecoin Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Currency Vending Or Dispenser Machinecashnotechequecoin Sector

Filter Your Search

FREE Trial plan for all new users!